Vol 1, No 2 (August 01, 2012): Translational Cancer Research

Editorial

Chain-reaction, a model of gene expression dynamics

Yidong Chen

PDF Pages: 59-60 Full Text (3766) COI Form Open Access

Original Article

A chain reaction approach to modelling gene pathways

Gary C. Cheng, Dung-Tsa Chen, James J. Chen, Seng-jaw Soong, Coral Lamartiniere, Stephen Barnes

PDF Pages: 61-73 Full Text (8597) COI Form Open Access

Review Articles

Expression and functions of semaphorins in cancer

Tzu-Pin Lu, Mong-Hsun Tsai, Chuhsing Kate Hsiao, Liang-Chuan Lai, Eric Y. Chuang

PDF Pages: 74-87 Full Text (11359) COI Form Open Access

MDM2 and MDMX: alone and together in regulation of p53

Miriam Shadfan, Vanessa Lopez-Pajares, Zhi-Min Yuan

PDF Pages: 88-99 Full Text (26933) COI Form Open Access

Sensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor κB kinase

Lijian Shao, Lixian Wu, Daohong Zhou

PDF Pages: 100-108 Full Text (9928) COI Form Open Access

Research Highlights

A balancing act for breast cancer? Everolimus for hormone receptor positive patients

Stephanie B Wheeler, Katherine Reeder-Hayes, Anne-Marie Meyer

PDF Pages: 109-112 Full Text (9982) COI Form Open Access

Do the results of BIG 1-98 assist with patient management decisions?

Jacquie Chirgwin

PDF Pages: 113-116 Full Text (5245) Open Access

Pertuzumab: a step forward in treating HER2-positive breast cancer

Dimitrios Mavroudis

PDF Pages: 117-118 Full Text (4201) COI Form Open Access

Targeting cancer with PI3K pathway inhibitors: who to aim at?

Kathryn M. Kinross, Karen E. Sheppard, Richard B. Pearson, Wayne A. Phillips

PDF Pages: 119-121 Full Text (3782) COI Form Open Access

Pertuzumab in metastatic breast cancer: unanswered questions

Ana Elisa Lohmann, Kamal S. Saini, Otto Metzger-Filho

PDF Pages: 122-124 Full Text (6011) COI Form Open Access